Effects of sex, age and BMI on screening tests for impaired glucose tolerance

Diabetes Research and Clinical Practice

Volumn 64, Issue 2, 2004, Pages 129-136

  Gomyo, Mioko ^a   Sakane, Naoki ^a,m   Kamae, Isao ^b   Sato, Shigeaki ^a   Suzuki, Ken Ichi ^c   Tominaga, Makoto ^d   Kawazu, Shoji ^e   Yoshinaga, Hideyo ^f   Tsushita, Kazuyo ^g   Sato, Juichi ^h   Sato, Yuzo ⁱ   Tsujii, Satoru ^j   Yoshida, Toshihide ^k   Seino, Yutaka ^l   Usui, Takeshi ^m   Nanjo, Kishio ⁿ   Hirata, Mari ^o   Kotani, Kazuhiko ^p   Hososako, Arimasa ^q   Kiyohara, Yutaka ^r   Kuzuya, Hideshi ^m   more..

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY   (Japan)

^c Division of Diabetes and Metabolism   (Japan)

^d YAMAGATA UNIVERSITY   (Japan)

^e SAITAMA MEDICAL UNIVERSITY   (Japan)

^f TORANOMON HOSPITAL   (Japan)

^g Aichi Compreh Health Science Center   (Japan)

^h NAGOYA UNIVERSITY HOSPITAL   (Japan)

ⁱ NAGOYA UNIVERSITY   (Japan)

^j TENRI HOSPITAL   (Japan)

^k KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^l KYOTO UNIVERSITY   (Japan)

^m NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

ⁿ WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^o OSAKA INTERNATIONAL UNIVERSITY   (Japan)

^p TOTTORI UNIVERSITY   (Japan)

^q Kyushu Med Inst for Occup Hlth   (Japan)

^r KYUSHU UNIVERSITY   (Japan)

more..

Author keywords

FPG; IGT; Prevention; ROC curve; Screening

Indexed keywords

ACCURACY; ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PARAMETER; PATIENT SELECTION; POPULATION RESEARCH; PRACTICE GUIDELINE; SCREENING; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADULT; AGING; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES COMPLICATIONS; DIABETES MELLITUS; FASTING; FEMALE; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; ROC CURVE; SEX CHARACTERISTICS;

EID: 11144358344     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2003.10.019     Document Type: Article

References (30)

1. King H., Aubert R.E., Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diab. Care. 21:1998;1414-1431.
2. Kuzuya T. Survey of diabetes mellitus by Ministry of Health and Welfare in 1997. Endocrinol. Diabetol. 14:2002;242-248. (in Japanese).
3. Sasaki A., Tominaga M., Eguchi H.et al. Comparison of the prevalence of diabetes mellitus and impaired glucose tolerance in Japan and other countries. J. Jpn. Diab. Soc. 41:1998;355-362. (in Japanese).
4. Hara H., Egusa G., Yamakido M., Kawate R. The high prevalence of diabetes mellitus and hyperinsulinemia among the Japanese-Americans living in Hawaii and Los Angeles. Diab. Res. Clin. Pract. 24(Suppl.):1994;S37-S42.
5. Fujimoto W.Y., Leonetti D.L., Kinyoun J.L.et al. Prevalence of diabetes mellitus and impaired glucose tolerance among second-generation Japanese-American men. Diabetes. 36:1987;721-729.
6. Yamasaki Y., Kawamori R., Matsushima H.et al. Asymptomatic hyperglycaemia is associated with increased intimal plus medial thickness of the carotid artery. Diabetologia. 38:1995;585-591.
7. Fujishima M., Kiyohara Y., Kato I.et al. Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study. Diabetes. 45(Suppl. 3):1996;S14-S16.
8. Tominaga M., Eguchi H., Manaka H., Igarashi K., Kato T., Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: The Funagata Diabetes Study. Diab. Care. 22:1999;920-924.
9. Knowler W.C., Barrett-Connor E., Fowler S.E.et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346:2002;393-403.
10. Tuomilehto J., Lindstrom J., Eriksson J.G.et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344:2001;1343-1350.
11. Chiasson J.-L., Josse R.G., Gomis R., Hanefeld M., Karasik A., Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 359:2002;2072-2077.
12. American Diabetes Association and National Institute of Diabetes, Digestive and Kidney Diseases, The prevention or delay of type 2 diabetes, Diab. Care 25 (2002) 742-749.
13. Narayan K.M., Hanson R.L., Pettitt D.J., Bennett P.H., Knowler W.C. A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM. Diab. Care. 19:1996;972-978.
14. Takahashi E., Yoshida K., Kondo T. Detecting impaired glucose tolerance based on medical decision making. Nippon Koshu Eisei Zasshi. 41:1994;237-242. (in Japanese).
15. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 143:1982;29-36.
16. Yano M., Maehata E., Shimomura H., Yamakado M., Kiyose H., Shiba T. Improvement of the sensitivity of glucose intolerance screening by combining 1,5-AG, hemoglobin A1c and fasting blood glucose. J. Jpn. Diab. Soc. 38:1995;255-260. (in Japanese).
17. Shima K., Endo J., Oimomi M.et al. Interlaboratory difference in HbA1c measurement in Japan: a report of the committee on an interlaboratory standarization of HbA1c determination. J. Jpn. Diab. Soc. 37:1994;855-864. (in Japanese).
18. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diab. Care 20 (1997) 1183-1197.
19. Hanley J.A., McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 148:1983;839-843.
20. American Diabetes Association, Screening for diabetes, Diab. Care 25(Suppl. 1)(2002) S21-S24.
21. Tsuji I., Nakamoto K., Hasegawa T.et al. Receiver operating characteristic analysis on fasting plasma glucose, HbA1c, and fructosamine on diabetes screening. Diab. Care. 14:1991;1075-1077.
22. Bortheiry A.L., Malerbi D.A., Franco L.J. The ROC curve in the evaluation of fasting capillary blood glucose as a screening test for diabetes and IGT. Diab. Care. 17:1994;1269-1272.
23. Harris M.I., Flegal K.M., Cowie C.C.et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: The Third National Health and Nutrition Examination Survey 1988-1994. Diab. Care. 21:1998;518-524.
24. Pomerleau J., McKeigue P.M., Chaturvedi N. Relationships of fasting and postload glucose levels to sex and alcohol consumption. Diab. Care. 22:1999;430-433.
25. The DECODE study group on behalf of the European Diabetes Epidemiology Group, Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies, Diabetologia 42 (1999) 647-654.
26. Simon D., Senan C., Garnier P., Saint-Paul M., Papoz L. Epidemiological features of glycated haemoglobin A1c-distribution in a healthy population: The Telecom study. Diabetologia. 32:1989;864-869.
27. Boeing H., Weisgerber U.M., Jeckel A., Rose H.-J., Kroke A. Association between glycated hemoglobin and diet and other lifestyle factors in a nondiabetic population: cross-sectional evaluation of data from the Potsdam cohort of the European Prospective Investigation into Cancer and Nutrition Study. Am. J. Clin. Nutr. 71:2000;1115-1122.
28. Nakashima K., Nishizaki O., Andoh Y. Acceleration of hemoglobin glycation with aging. Clin. Chim. Acta. 215:1993;111-118.
29. Wiener K., Roberts N.B. Age does not influence levels of HbA1c in normal subject. QJM. 92:1999;169-173.
30. World Health Organization, Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus, World Health Organisation, Geneva, 1999.